“Exploring the Potential of Drug Repurposing: Detection of Cystic Fibrosis Transmembrane Conductance Regulator as a Biomarker in Breast Cancer Patients”, Precis. Med. Com., vol. 3, no. 1, pp. 11–26, Jun. 2023, doi: 10.55627/pmc.003.01.0300.